The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study
Journal of Women's Health · 2023
DOI: 10.1089/jwh.2023.0058 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Women's Health, 2023. Verfasst von Xiaoping Xiao und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospi…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate the triaging efficacy of the human papillomavirus (HPV) 16/18 E7 oncoprotein assay for high-grade cervical intraepithelial neoplasia (CIN2+) screening in HPV 16/18-positive patients in a tertiary hospital in China.
Methods
We collected 476 cervical cell samples from women who tested positive for HPV 16/18 in the gynecological clinic of Peking Union Medical College Hospital between September 2018 and September 2022 and analyzed them by the HPV 16/18 E7 oncoprotein assay before colposcopy and biopsy. The study assessed the triaging efficacy of the HPV 16/18 E7 oncoprotein assay in HPV 16/18-positive patients by analyzing its performance against the gold standard of histologically confirmed CIN2+.
Results
The positive rate of the HPV 16/18 E7 oncoprotein assay was 41.0% (114/278) in the negative for intraepithelial lesions and malignancy/CIN1 group and 80.3% (159/198) in the CIN2+ group. For triage of women with a positive HPV 16/18 test for CIN2+ detection, the HPV 16/18 E7 oncoprotein assay had a sensitivity, specificity, positive predictive value, and negative predictive value of 80.3%, 59.4%, 58.5%, and 80.9%, respectively. Furthermore, longitudinal follow-up of five patients showed a good correlation between the expression of the HPV 16/18 E7 oncoprotein and cervical lesion grades.
Conclusions
As a triage method for HPV 16/18-positive patients, the HPV 16/18 E7 oncoprotein assay improves the specificity, reduces the colposcopy referral rate, and has the potential for long-term monitoring of high-grade CIN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Coll…
- Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Beijing, China.
- Department of Endocrinology, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Beijing, China.
- Research and Development Department, FAMID Biomedical Technology (Tianjin) Co., Ltd., Tianjin, China.
Zitieren
APA
Xiao, X., Cao, Y., Bi, K., Wang, W., Yang, J., Wang, J., Li, Y., Li, C., Guan, R., Zhang, Y., Wang, J., Song, S., Zhu, L., & Shi, H. (2023). The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.0058
Vancouver
Xiao X, Cao Y, Bi K, Wang W, Yang J, Wang J, et al. The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study. Journal of Women's Health. 2023. doi:10.1089/jwh.2023.0058
BibTeX
@article{Xiao2023,
author = {Xiao, Xiaoping and Cao, Yang and Bi, Kaihua and Wang, Wei and Yang, Junjun and Wang, Jinhui and Li, Yan and Li, Caijuan and Guan, Ruoli and Zhang, Ying and Wang, Jin and Song, Shuhui and Zhu, Lan and Shi, Honghui},
title = {The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study},
journal = {Journal of Women's Health},
year = {2023},
doi = {10.1089/jwh.2023.0058}
}
EUVIMED